|
|
Prospectus Supplement No. 8
|
|
|
Filed Pursuant to Rule 424(b)(3)
|
|
|
File No. 333-138803
|
Prospectus Supplement No. 8
(to Final Prospectus dated August 9, 2007)
This
Prospectus Supplement No. 8 supplements and amends the final prospectus
dated August 9, 2007, as supplemented and amended by Supplement No. 1
thereto dated August 21, 2007, Supplement No. 2 thereto dated September 11,
2007, Supplement No. 3 thereto dated September 14, 2007, Supplement No. 4
thereto dated September 19, 2007, Supplement No. 5 thereto dated October 11,
2007, Supplement No. 6 thereto dated October 22, 2007 and Supplement No. 7
thereto dated December 10, 2007 (collectively, the Final Prospectus),
relating to the sale from time to time of up to 892,857 shares of our common stock by certain selling
shareholders.
On February 22, 2008,
we filed with the U.S. Securities and Exchange Commission a Current Report on Form 8-K
relating to our Board of Directors recent grants of restricted stock and stock
options to certain executive officers, as well as amendments made to stock
option plans, our Management Incentive Plan, and forms of agreement. This report is attached to this Prospectus
Supplement. The attached information
supplements and supersedes, in part, the information contained in the Final
Prospectus.
This
Prospectus Supplement No. 8 should be read in conjunction with the Final
Prospectus and is qualified by reference to the Final Prospectus except to the
extent that the information in this Prospectus Supplement No. 8 supersedes
the information contained in the Final Prospectus.
Our shares of
common stock are quoted on the OTC Bulletin Board and trade under the ticker
symbol MCVI. On February 21,
2008, the closing price of a share on the OTC Bulletin Board was $2.20.
Investing in our common stock involves a high
degree of risk, including the risk that we have no assurance of future
profitability and the fact that the report of our independent registered
public accounting firm expresses doubt about our ability to continue as a
going concern. See Risk Factors beginning on page 5 of the
Final Prospectus dated August 9, 2007.
Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or determined if this
Prospectus Supplement No. 8 is truthful or complete. Any representation to the contrary is a
criminal offense.
The
date of this Prospectus Supplement No. 8 is February 22, 2008.
ITEM 5.02 DEPARTURE OF
DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN
OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS
(e)
Awards of Restricted Stock and Options
On February 15, 2008, our Board of Directors, acting on the
recommendation of our Compensation Committee,
made
equity awards to certain of our executive officers as follows:
Restricted Stock Awards
85,000 to Marc P. Flores, our President and Chief Executive Officer
15,000 to Adam L. Berman, our Vice President, Research and Development
15,000 to Michael A. Brodeur, our Vice President, Finance and Chief
Financial Officer
15,000 to Robert W. Clapp, our Vice President, Operations
15,000 to Gary O. Tegan, our Vice President, Marketing
Each restricted stock award provides that the
recipient will receive unrestricted shares of common stock if he has been
continuously in our employment for four years from the date of grant.
Non-Qualified Stock Options
250,000 to Marc P. Flores, our President and Chief Executive Officer
50,000 to Adam L. Berman, our Vice President, Research and Development
50,000 to Michael A. Brodeur, our Vice President, Finance and Chief
Financial Officer
50,000 to Robert W. Clapp, our Vice President, Operations
50,000 to Gary O. Tegan, our Vice President, Marketing
The foregoing options were each issued under
our Amended and Restated 2001 Equity Incentive Plan, with the exception that
150,000 of the options granted to Mr. Flores were issued outside our employee
benefit plans. All the options vest to
the extent of one-third on the first anniversary of completion of a financial
milestone, and vest to the extent of one-third annually thereafter. They are exercisable at $2.35 per share,
which represented the fair market value of our common stock on February 15,
2008. These options expire on February
15, 2018.
Amendments to Stock Option Plans and Award Agreements
Effective February 15, 2008, our Board of Directors, acting on the
recommendation of our Compensation Committee, also amended our Amended and
Restated 2001 Equity Incentive Plan (EIP) and our Amended and Restated 2005
Director Stock Option Plan to exclude from the acquisition prong of the
definition of a change in control an acquisition of the majority of the
companys outstanding stock by acquisition of stock directly from the
company. Our Board also amended the
Management Incentive Plan to add the same definition of change in control.
In addition, our Compensation Committee approved, by written action
dated February 21, 2008, amended forms of award agreements, including the Form
of Non-Qualified Stock Option Agreement under the EIP, the Form of Stand-Alone
Non-Qualified Stock Option Agreement, and the Form of Restricted Stock
Award. As amended, these agreements
include or incorporate the amended definition of change in control.
The amended definition of change in control applies to the awards made
on February 15, 2008. The form of
amendment to previous non-qualified stock option grants applies the amended
definition of change in control to unvested stock options previously issued
outside of the EIP held by the three executives receiving the new awards who
also hold such stand-alone options.
The foregoing description is qualified in its entirety by reference to
the documents themselves, which are attached as exhibits to this Current Report
on Form 8-K
.
ITEM 9.01 FINANCIAL
STATEMENTS AND EXHIBITS
(d) Exhibits
See Exhibit Index.
2
Exhibit Index
|
Exhibit Number
|
|
Description
|
|
10.1
|
|
First Amendment to the Amended and Restated
2001 Equity Incentive Plan.
|
|
10.2
|
|
First Amendment to the Amended and Restated
2005 Director Stock Option Plan.
|
|
10.3
|
|
First Amendment to the Management Incentive
Plan.
|
|
10.4
|
|
Form of Non-Qualified Stock Option
Agreement under the Amended and Restated 2001 Equity Incentive Plan.
|
|
10.5
|
|
Form of Stand-Alone Non-Qualified
Stock Option Agreement.
|
|
10.6
|
|
Form of Restricted Stock Award.
|
|
10.7
|
|
Form of Amendment to Previous
Non-Qualified Stock Option Grants.
|
4
Exhibit 10.1
FIRST AMENDMENT
TO THE
MEDICALCV, INC.
AMENDED AND RESTATED 2001 EQUITY INCENTIVE PLAN
In accordance with Section 11
of the Amended and Restated 2001 Equity Incentive Plan (the Plan), which
permits the Board to amend the Plan, the Plan is hereby amended effective as of
February 15, 2008. Section 1.3
shall be amended and restated as follows:
1.3
Change in Control.
The term Change in Control shall mean:
(a) the acquisition by any person or group
deemed a person under Sections 3(a)(9) and 13(d)(3) of the Exchange
Act (other than the Company and its subsidiaries as determined immediately
prior to that date) of beneficial ownership, directly or indirectly (with
beneficial ownership determined as provided in Rule 13d-3, or any
successor rule, under the Exchange Act), of a majority of the total combined
voting power of all classes of Stock of the Company having the right under
ordinary circumstances to vote at an election of the Board, provided that a
Change in Control shall not occur if a person acquires the majority described
above by virtue of any acquisition of Stock directly from the Company;
(b) the date of approval by the
shareholders of the Company of an agreement providing for the merger or
consolidation of the Company with another corporation or other entity where (x) shareholders
of the Company immediately prior to such merger or consolidation would not
beneficially own following such merger or consolidation shares entitling such
shareholders to a majority of all votes (without consolidation of the rights of
any class of stock to elect directors by a separate class vote) to which all
shareholders of the surviving corporation would be entitled in the election of
directors, or (y) where the members of the Board, immediately prior to such
merger or consolidation, would not, immediately after such merger or
consolidation, constitute a majority of the board of directors of the surviving
corporation; or
(c) the sale of all or substantially all
of the assets of the Company.
Dated: February 22, 2008
|
|
MEDICALCV, INC.
|
|
|
|
|
|
|
|
|
By:
|
Michael A. Brodeur
|
|
|
Its:
|
Vice President, Finance and Chief Financial
Officer
|
Exhibit 10.2
FIRST AMENDMENT
TO THE
MEDICALCV, INC.
AMENDED AND RESTATED 2005 DIRECTOR STOCK OPTION PLAN
In accordance with Section 8
of the Amended and Restated Director Stock Option Plan (the Plan), which
permits the Board to amend the Plan, the Plan is hereby amended effective as of
February 15, 2008. Section 6(d) shall
be amended and restated as follows:
(d) Change of
Control means any one of the following:
(i) the acquisition by any person or group
deemed a person under Sections 3(a)(9) and 13(d)(3) of the Exchange
Act (other than the Company and its subsidiaries as determined immediately
prior to that date) of beneficial ownership, directly or indirectly (with
beneficial ownership determined as provided in Rule 13d-3, or any
successor rule, under the Exchange Act), of a majority of the total combined
voting power of all classes of Stock of the Company having the right under
ordinary circumstances to vote at an election of the Board, provided that a
Change in Control shall not occur if a person acquires the majority described
above by virtue of any acquisition of Stock directly from the Company;
(ii) the date of approval by the shareholders
of the Company of an agreement providing for the merger or consolidation of the
Company with another corporation or other entity where (x) shareholders of
the Company immediately prior to such merger or consolidation would not
beneficially own following such merger or consolidation shares entitling such
shareholders to a majority of all votes (without consolidation of the rights of
any class of stock to elect directors by a separate class vote) to which all
shareholders of the surviving corporation would be entitled in the election of
directors, or (y) where the members of the Board, immediately prior to
such merger or consolidation, would not, immediately after such merger or
consolidation, constitute a majority of the board of directors of the surviving
corporation; or
(iii) the sale of all or substantially all of
the assets of the Company.
Dated: February 22, 2008
|
|
MEDICALCV, INC.
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
Michael A. Brodeur
|
|
|
Its:
|
Vice President, Finance and Chief Financial
Officer
|
|
|
|
|
|
Exhibit 10.3
FIRST AMENDMENT
TO THE
MEDICALCV, INC.
MANAGEMENT INCENTIVE PLAN
Effective as of February 15,
2008, the Management Incentive Plan (MIP) shall be amended to read as
follows:
1. The following shall be added to the Section titled,
Payment in the Event of a Change in Control:
For purposes of this Plan, change in control shall mean:
(a) the acquisition by any person or
group deemed a person under Sections 3(a)(9) and 13(d)(3) of the
Exchange Act (other than the Company and its subsidiaries as determined
immediately prior to that date) of beneficial ownership, directly or indirectly
(with beneficial ownership determined as provided in Rule 13d-3, or any
successor rule, under the Exchange Act), of a majority of the total combined
voting power of all classes of Stock of the Company having the right under
ordinary circumstances to vote at an election of the Board, provided that a
Change in Control shall not occur if a person acquires the majority described
above by virtue of any acquisition of Stock directly from the Company;
(b) the date of approval by the
shareholders of the Company of an agreement providing for the merger or
consolidation of the Company with another corporation or other entity where (x) shareholders
of the Company immediately prior to such merger or consolidation would not
beneficially own following such merger or consolidation shares entitling such
shareholders to a majority of all votes (without consolidation of the rights of
any class of stock to elect directors by a separate class vote) to which all
shareholders of the surviving corporation would be entitled in the election of
directors, or (y) where the members of the Board, immediately prior to
such merger or consolidation, would not, immediately after such merger or consolidation,
constitute a majority of the board of directors of the surviving corporation;
or
(c) the sale of all or substantially all
of the assets of the Company.
Dated: February 22, 2008
|
|
MEDICALCV, INC.
|
|
|
|
|
|
|
By:
|
Michael A. Brodeur
|
|
|
Its:
|
Vice President, Finance and Chief Financial
Officer
|
|
|
|
|
|
Exhibit 10.4
MEDICALCV, INC.
NON-QUALIFIED STOCK OPTION AGREEMENT
PURSUANT TO AMENDED AND RESTATED 2001 EQUITY INCENTIVE
PLAN
|
No. of shares
subject to option:
|
|
Option No.:
|
|
Date of grant:
|
|
|
THIS OPTION AGREEMENT is entered into by and between MedicalCV, Inc.,
a Minnesota corporation (the Company), and
(the Optionee) pursuant to the Companys Amended and Restated 2001 Equity
Incentive Plan (the Plan). Unless
otherwise defined herein, certain capitalized terms shall have the meaning set
forth in the Plan.
W I T N E S S E T
H:
1.
Nature of the Option
. This Option is not intended to qualify as an
Incentive Stock Option within the meaning of Section 422 of the United
States Internal Revenue Code of 1986, as amended.
2.
Grant of Option
.
Pursuant to the provisions of the Plan, the Company grants to the
Optionee, subject to the terms and conditions of the Plan and to the terms and
conditions herein set forth, the right and option to purchase from the Company
all or a part of an aggregate of
( )
shares of Stock (the Shares) at the purchase price of
$ per
share, such Option to be exercised as hereinafter provided. The exercise price is not less than the fair
market value of the stock on the date of the grant.
3.
Terms and Conditions
. It is understood and agreed that the Option
evidenced hereby is subject to the following terms and conditions:
(a)
Expiration Date
. This Option shall expire ten years after the
date of grant specified above.
Notwithstanding the foregoing, if the Optionees employment or
relationship with the Company or Related Company is terminated by reason of
death, Disability or Retirement, this Option shall expire on the one-year
anniversary of the termination date. If
the Optionees employment or relationship with the Company or Related Company
is terminated by reasons for other than death, Disability or Retirement, this
Option shall, subject to Section 4 of the Plan, expire on the three-month
anniversary of the termination date.
Except as otherwise provided by the Board, an Optionee shall be
considered to have a Disability if the Optionee is unable, by reason of a
medically determinable physical or mental impairment, to substantially perform
the principal duties of employment with the Company, which condition, in the
opinion of a physician selected by the Board, is expected to have a duration of
not less than 120 days.
(b)
Exercise
of Option
. Subject to the Plan and the
other terms of this Agreement regarding the exercisability of this Option, this
Option shall be exercisable cumulatively, to the extent it is vested, as set
forth in Exhibit A. Any exercise
shall be accompanied by a written notice to the Company specifying the number
of shares of Stock as to which the Option is being exercised. Notation of any partial exercise shall be
made by the Company on Schedule I hereto.
This Option
may not be
exercised for a fraction of a Share, and must be exercised for no fewer than
one hundred (100) shares of Stock, or such lesser number of shares as may be
vested.
(c)
Payment
of Purchase Price Upon Exercise
. At
the time of any exercise, the Exercise Price of the Shares as to which this
Option is exercised shall be paid in cash to the Company, unless, in accordance
with the provisions of Section 4.2(c) of the Plan, the Board shall
permit or require payment of the purchase price in another manner set forth in
the Plan. This Option does not include
any feature for the deferral of compensation following its exercise.
(d)
Nontransferability
. This Option shall not be transferable other
than by will or by the laws of descent and distribution. During the lifetime of the Optionee, this
Option shall be exercisable only by the Optionee or by the Optionees guardian
or legal representative. No transfer of
this Option by the Optionee by will or by the laws of descent and distribution
shall be effective to bind the Company unless the Company is furnished with
written notice thereof and a copy of the will and/or such other evidence as the
Board may determine necessary to establish the validity of the transfer.
(e)
Acceleration
of Option Upon Change in Control
. In
the event of a Change in Control, as defined in Section 1.3 of the Plan,
the provisions of Section 3(b) and Exhibit A hereof pertaining
to vesting shall cease to apply and this Option shall become immediately vested
and fully exercisable with respect to all Shares; provided, however, that the
provisions of this Subsection 3(e) shall not apply unless the Optionee has
been employed by the Company for a period equal to or exceeding one calendar
year. No acceleration of vesting shall
occur under this Subsection 3(e) in the event a surviving corporation or
its parent assumes this Option or in the event the surviving corporation or its
parent substitutes an option agreement with substantially the same terms as
provided in this Agreement. Nothing in
this Subsection 3(e) shall limit the Committees authority to cancel this
Option in accordance with Section 9 of the Plan.
(f)
Subject
to Lock Up
. Optionee understands
that the Company at a future date may file a registration or offering statement
(the Registration Statement) with the Securities and Exchange Commission to
facilitate an underwritten public offering of its securities. The Optionee agrees, for the benefit of the
Company, that should such an underwritten public offering be made and should
the managing underwriter of such offering require, the undersigned will not, without
the prior written consent of the Company and such underwriter, during the Lock
Up Period as defined herein: sell, transfer or otherwise dispose of, or agree
to sell, transfer or otherwise dispose of this Option or any of the Shares
acquired upon exercise of this Option during the Lock Up Period; or sell or
grant, or agree to sell or grant, options, rights or warrants with respect to
any of the Shares acquired upon exercise of this Option. The foregoing does not prohibit gifts to
donees or transfers by will or the laws of descent to heirs or beneficiaries
provided that such donees, heirs and beneficiaries shall be bound by the
restrictions set forth herein. The term Lock
Up Period shall mean the lesser of (x) 180 days or (y) the period
during which Company officers and directors are restricted by the managing
underwriter from effecting any sales or transfers of the Shares. The Lock Up Period shall commence on the
effective date of the Registration Statement.
(g)
Not
An Employment Contract
. The Option
will not confer on the Optionee any right with respect to continuance of
employment or other service with the Company or any Subsidiary,
2
nor will it
interfere in any way with any right the Company or any Subsidiary would
otherwise have to terminate or modify the terms of such Optionees employment
or other service at any time.
(h)
No
Rights as Shareholder
. The Optionee
shall have no rights as a shareholder of the Company with respect to any Shares
prior to the date of issuance to the Optionee of a certificate for such Shares.
(i)
Compliance
with Law and Regulations
. This
Option and the obligation of the Company to sell and deliver Shares hereunder
shall be subject to all applicable laws, rules and regulations (including,
but not limited to, federal securities laws) and to such approvals by any
government or regulatory agency as may be required. This Option shall not be exercisable, and the
Company shall not be required to issue or deliver any certificates for Shares
of Stock prior to the completion of any registration or qualification of such
Shares under any federal or state law, or any rule or regulation of any
government body which the Company shall, in its sole discretion, determine to
be necessary or advisable. Moreover,
this Option may not be exercised if its exercise or the receipt of Shares of
Stock pursuant thereto would be contrary to applicable law.
(j)
Withholding
. All deliveries and distributions under this
Agreement are subject to withholding of all applicable taxes. The Company is entitled to (a) withhold
and deduct from future wages of the Optionee (or from other amounts that may be
due and owing to the Optionee from the Company), or make other arrangements for
the collection of, all legally required amounts necessary to satisfy any
federal, state or local withholding and employment-related tax requirements
attributable to the Option, or (b) require the Optionee promptly to remit
the amount of such withholding to the Company before acting on the Optionees
notice of exercise of this Option. At
the election of the Optionee, and subject to such rules and limitations as
may be established by the Committee from time to time, such withholding
obligations may be satisfied through the surrender of shares of Stock which the
Optionee already owns, or to which the Optionee is otherwise entitled under the
Plan.
4.
Termination
of Employment
. Upon the termination
of the employment of Optionee prior to the expiration of the Option, the following
provisions shall apply:
(a) Upon
the Involuntary Termination of Optionees employment or the voluntary
termination or resignation of Optionees employment, the Optionee may exercise
the Option to the extent the Optionee was vested in and entitled to exercise
the Option at the date of such employment termination for a period of three (3) months
after the date of such employment termination, or until the term of the Option
has expired, whichever date is earlier.
To the extent the Optionee was not entitled to exercise this Option at
the date of such employment termination, or if Optionee does not exercise this
Option within the time specified herein, this Option shall terminate.
(b) If
the employment of an Optionee is terminated by the Company for cause, then the
Board or the Committee shall have the right to cancel the Option.
5.
Death,
Disability or Retirement of Optionee
.
Upon the death, Disability or Retirement, as defined herein, of Optionee
prior to the expiration of the Option, the following provisions shall apply:
3
(a) If
the Optionee is at the time of his Disability employed by the Company or a
Subsidiary and has been in continuous employment (as determined by the
Committee in its sole discretion) since the Date of Grant of the Option, then
the Option may be exercised by the Optionee for one (1) year following the
date of such Disability or until the expiration date of the Option, whichever
date is earlier, but only to the extent the Optionee was vested in and entitled
to exercise the Option at the time of his Disability. For purposes of this Section 5, the term
Disability shall mean that the Optionee is unable, by reason of a medically
determinable physical or mental impairment, to substantially perform the
principal duties of employment with the Company, which condition, in the
opinion of a physician selected by the Board, is expected to have a duration of
not less than 120 days, unless the Optionee is employed by the Company, a
Parent, a Subsidiary or an Affiliate, pursuant to an employment agreement which
contains a definition of Disability, in which case such definition shall
control. The Committee, in its sole
discretion, shall determine whether an Optionee has a Disability and the date of
such Disability.
(b) If
the Optionee is at the time of his death employed by the Company or a
Subsidiary and has been in continuous employment (as determined by the
Committee in its sole discretion) since the Date of Grant of the Option, then
the Option may be exercised by the Optionees estate or by a person who
acquired the right to exercise the Option by will or the laws of descent and
distribution, for one (1) year following the date of the Optionees death
or until the expiration date of the Option, whichever date is earlier, but only
to the extent the Optionee was vested in and entitled to exercise the Option at
the time of death.
(c) If
the Optionee is at the time of his Retirement employed by the Company or a
Subsidiary and has been in continuous employment (as determined by the
Committee in its sole discretion) since the Date of Grant of the Option, then
the Option may be exercised by the Optionee for one (1) year following the
date of the Optionees Retirement or until the expiration date of the Option,
whichever date is earlier, but only to the extent the Optionee was vested in
and entitled to exercise the Option at the time of Retirement. For purposes of this Section 5,
Retirement of the Optionee shall mean, with the approval of the Committee, the
occurrence of the Optionees Date of Termination on or after the date the
Optionee attains age 55.
(d) If
the Optionee dies within three (3) months after Termination of Optionees
employment with the Company or a Subsidiary the Option may be exercised for
nine (9) months following the date of Optionees death or the expiration
date of the Option, whichever date is earlier, by the Optionees estate or by a
person who acquires the right to exercise the Option by will or the laws of
descent or distribution, but only to the extent the Optionee was vested in and
entitled to exercise the Option at the time of Termination.
6.
Termination
of Relationship for Misconduct; Clawback
.
If the Board or the Committee reasonably believes that the Optionee has
committed an act of misconduct or breach of fiduciary duty, it may suspend the
Optionees right to exercise this option pending a determination by the Board
or the Committee. If the Board or the
Committee determines that the Optionee has committed an act of misconduct or has breached a duty to the
Company, neither the Optionee nor the Optionees estate shall be entitled to
exercise the Option. For purposes of
this Section 6, an act of misconduct shall include embezzlement, fraud,
dishonesty, nonpayment of an obligation owed to the Company, breach of
fiduciary duty or deliberate disregard of the Companys rules resulting in
loss, damage or injury to the Company, or if the Optionee makes an unauthorized
disclosure of any
4
Company trade
secret or confidential information, engages in any conduct constituting unfair
competition with respect to the Company, or induces any party to breach a
contract with the Company. In making
such determination, the Board or the Committee shall act fairly and shall give
the Optionee an opportunity to appear and present evidence on the Optionees
behalf at a hearing before the Board or the Committee. For purposes of this Section 6, an act
of misconduct or breach of fiduciary duty to the Company shall be an event
giving the Company the right to terminate Optionees employment pursuant to Section
of Optionees Employment Agreement with the Company dated
,
which Agreement is incorporated herein by reference. In addition, misconduct shall include willful
violations of federal or state securities laws.
In making such determination, the Board or the Committee shall act fairly
and shall give the Optionee an opportunity to appear and present evidence on
the Optionees behalf at a hearing before the Board or the Committee. In addition, if the Company, based upon an
opinion of legal counsel or a judicial determination, determines that Section 304
of the Sarbanes-Oxley Act of 2002 is applicable to Optionee hereunder, to the
extent that the Company is required to prepare an accounting restatement due to
the material noncompliance of the Company, as a result of misconduct, with any
financial reporting requirement under the securities laws, Optionee shall reimburse
the Company for any compensation received by Optionee from the Company during
the 12-month period following the first public issuance or filing with the
Securities and Exchange Commission (whichever first occurs) of the financial
document embodying such financial reporting requirement and any profits
received from the sale of the Companys common stock or common stock
equivalents, acquired pursuant to this Agreement.
7.
Optionee
Bound by Plan
. The Optionee hereby
acknowledges receipt of a copy of the Plan and agrees to be bound by all the
terms and provisions thereof. In the
event of any question or inconsistency between this Agreement and the Plan, the
terms and conditions of the Plan shall govern.
8.
Heirs
and Successors
. This Agreement shall
be binding upon, and inure to the benefit of, the Company and its successors
and assigns, and upon any person acquiring, whether by merger, consolidation,
purchase of assets or otherwise, all or substantially all of the Companys
assets and business. If any rights
exercisable by the Optionee or benefits deliverable to the Optionee under this
Agreement have not been exercised or delivered, respectively, at the time of
the Optionees death, such rights shall be exercisable by the Designated
Beneficiary, and such benefits shall be delivered to the Designated
Beneficiary, in accordance with the provisions of this agreement and the
Plan. The Designated Beneficiary shall
be the beneficiary or beneficiaries designated by the Optionee in a writing
filed with the Committee in such form and at such time as the Committee shall
require. If a deceased Optionee fails to
designate a beneficiary, or if the Designated Beneficiary does not survive the
Optionee, any rights that would have been exercisable by the Optionee and any
benefits distributable to the Optionee shall be exercised by or distributed to
the legal representative of the estate of the Optionee. If a deceased Optionee designates a
beneficiary and the Designated Beneficiary survives the Optionee but dies before
the Designated Beneficiarys exercise of all rights under this Agreement or
before the complete distribution of benefits to the Designated Beneficiary
under this Agreement, then any rights that would have been exercisable by the
Designated Beneficiary shall be exercised by the legal representative of the
estate of the Designated Beneficiary, and any benefits distributable to the
Designated Beneficiary shall be distributed to the legal representative of the
estate of the Designated Beneficiary.
5
9.
Plan
Governs
. Notwithstanding anything in
this Agreement to the contrary, the terms of this Agreement shall be subject to
the terms of the Plan, a copy of which may be obtained by the Optionee from the
office of the Secretary of the Company; and this Agreement is subject to all
interpretations, amendments, rules and regulations promulgated by the
Committee from time to time pursuant to the Plan.
10.
Notices
. Any notice hereunder to the Company shall be
addressed to it at its principal executive offices, located at 9725 South
Robert Trail, Inver Grove Heights, Minnesota 55077, Attention: Chief Executive
Officer; and any notice hereunder to the Optionee shall be addressed to the
Optionee at the address last appearing in the employment records of the
Company; subject to the right of either party to designate at any time
hereunder in writing some other address.
11.
Counterparts
. This Agreement may be executed in two
counterparts each of which shall constitute one and the same instrument.
12.
Governing
Law
. This Agreement shall be
governed by and construed in accordance with the laws of the State of
Minnesota, except to the extent preempted by federal law, without regard to the
principles of comity or the conflicts of law provisions of any other
jurisdiction.
IN WITNESS
WHEREOF, MedicalCV, Inc. has caused this Agreement to be executed by its
duly authorized officer and the Optionee has executed this Agreement, both as
of the day and year first above written.
|
|
MEDICALCV, INC.
|
|
|
|
|
|
|
|
|
|
|
|
By [Name]
|
|
|
Its [Title]
|
|
|
|
|
OPTIONEE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Address:
|
|
|
|
|
|
|
|
|
|
|
|
|
6
EXHIBIT A
OPTION AND VESTING DATA
Name of Optionee:
Total Number of Shares
Subject to Option:
Date of Grant:
OPTION VESTING SCHEDULE
|
|
|
NO. OF SHARES
|
|
|
DATE
|
|
VESTED
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The above vesting schedule assumes an ongoing
relationship with the Company. Your
rights to exercise the unvested portion of your option will cease upon
termination of relationship with the Company, subject to Change in Control
provisions set forth in the Plan.
Reference is made to the Plan and to relevant sections of the Agreement
between you and the Company for your rights to exercise the vested portion of
your option in the event of termination of your relationship with the Company
during lifetime or upon death. The above
vesting schedule is in all respects subject to the terms of those documents.
|
OPTIONEE
|
|
|
MEDICALCV, INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
|
|
|
|
Its:
|
|
SCHEDULE I -
NOTATIONS AS TO PARTIAL EXERCISE
|
|
|
Number of
|
|
Balance of
|
|
|
|
|
|
|
Date of
|
|
Purchased
|
|
Shares on
|
|
Authorized
|
|
Notation
|
|
|
Exercise
|
|
Shares
|
|
Option
|
|
Signature
|
|
Date
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit 10.5
THE OPTION REPRESENTED
HEREBY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN
EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR AN OPINION OF COUNSEL, SATISFACTORY
TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.
MEDICALCV, INC.
NON-QUALIFIED STOCK OPTION AGREEMENT
|
No. of shares
subject to option:
|
|
Option No.:
NQO-
|
|
Date of grant:
|
|
|
THIS OPTION
AGREEMENT is entered into by and between MedicalCV, Inc., a Minnesota
corporation (the Company), and
(the Optionee).
W I T N E S S E T
H:
WHEREAS, in connection with his/her employment, the
Company has agreed to grant Optionee an option to purchase shares of its common
stock outside the Companys stock option plans; and
WHEREAS, the Compensation Committee of the Company (Committee)
has authorized and approved the grant of the following option (Option) on the
terms set forth in this Agreement,
NOW, THEREFORE, in consideration of the mutual
covenants hereinafter set forth and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties
hereto have agreed, and do hereby agree, as follows:
1.
Nature
of the Option
. This Option is not
intended to qualify as an Incentive Stock Option within the meaning of Section 422
of the United States Internal Revenue Code of 1986, as amended. This Option is not granted pursuant to the
Companys Amended and Restated 2001 Equity Incentive Plan.
2.
Grant
of Option
. The Company grants to the
Optionee, subject to the terms and conditions of this Agreement, the right and
option to purchase from the Company all or a part of an aggregate of
( )
shares of Stock (the Shares) at the purchase price of
$ per share, such Option to be
exercised as hereinafter provided. The
exercise price is not less than the fair market value of the stock on the date
of the grant.
3.
Terms
and Conditions
. It is understood and
agreed that the Option evidenced hereby is subject to the following terms and
conditions:
(a)
Expiration
Date
. This Option shall expire ten
years after the date of grant specified above.
Notwithstanding the foregoing, if the Optionees employment or
relationship with the Company or Related Company is terminated by reason of
death, Disability or Retirement, this
Option shall
expire on the one-year anniversary of the termination date. If the Optionees employment or relationship
with the Company or Related Company is terminated by reasons for other than
death, Disability or Retirement, this Option shall, subject to the other terms
of this Agreement regarding the exercisability of this Option, expire on the three-month
anniversary of the termination date.
(b)
Exercise
of Option
. Subject to the other
terms of this Agreement regarding the exercisability of this Option, this
Option shall be exercisable cumulatively, to the extent it is vested, as set
forth in Exhibit A. Any exercise
shall be accompanied by a written notice to the Company specifying the number
of shares of Stock as to which the Option is being exercised. Notation of any partial exercise shall be
made by the Company on Schedule I hereto.
This Option may not be exercised for a fraction of a Share, and must be
exercised for no fewer than one hundred (100) shares of Stock, or such lesser
number of shares as may be vested.
(c)
Payment
of Purchase Price Upon Exercise
. At
the time of any exercise, the Exercise Price of the Shares as to which this
Option is exercised shall be paid in cash to the Company, unless the Board
shall permit or require payment of the purchase price in another manner. This Option does not include any feature for
the deferral of compensation following its exercise.
(d)
Nontransferability
. This Option shall not be transferable other
than by will or by the laws of descent and distribution. During the lifetime of the Optionee, this
Option shall be exercisable only by the Optionee or by the Optionees guardian
or legal representative. No transfer of
this Option by the Optionee by will or by the laws of descent and distribution
shall be effective to bind the Company unless the Company is furnished with
written notice thereof and a copy of the will and/or such other evidence as the
Board may determine necessary to establish the validity of the transfer.
(e)
Acceleration
of Option Upon Change in Control
. In
the event of a Change in Control, as defined below, the provisions of Section 3(b) and
Exhibit A hereof pertaining to vesting shall cease to apply and this
Option shall become immediately vested and fully exercisable with respect to
all Shares; provided, however, that the provisions of this Subsection 3(e) shall
not apply unless the Optionee has been employed by the Company for a period
equal to or exceeding one calendar year.
No acceleration of vesting shall occur under this Subsection 3(e) in
the event a surviving corporation or its parent assumes this Option or in the
event the surviving corporation or its parent substitutes an option agreement
with substantially the same terms as provided in this Agreement. Nothing in this Subsection 3(e) shall
limit the Committees authority to cancel this Option in accordance with Section 6. For purposes of this Agreement, the term Change
in Control shall mean:
(i) the acquisition by
any person or group deemed a person under Sections 3(a)(9) and 13(d)(3) of
the Exchange Act (other than the Company and its subsidiaries as determined
immediately prior to that date) of beneficial ownership, directly or indirectly
(with beneficial ownership determined as provided in Rule 13d-3, or any
successor rule, under the Exchange Act), of a majority of the total combined
voting power of all classes of Stock of the Company having the right under
ordinary circumstances to vote at an election of the Board, provided that a
Change in Control shall not occur if a person acquires the majority described
above by virtue of any acquisition of Stock directly from the Company;
2
(ii) the date of
approval by the shareholders of the Company of an agreement providing for the
merger or consolidation of the Company with another corporation or other entity
where (x) shareholders of the Company immediately prior to such merger or
consolidation would not beneficially own following such merger or consolidation
shares entitling such shareholders to a majority of all votes (without
consolidation of the rights of any class of stock to elect directors by a
separate class vote) to which all shareholders of the surviving corporation
would be entitled in the election of directors, or (y) where the members
of the Board, immediately prior to such merger or consolidation, would not, immediately
after such merger or consolidation, constitute a majority of the board of
directors of the surviving corporation; or
(iii) the sale of all or
substantially all of the assets of the Company.
(f)
Subject
to Lock Up
. Optionee understands
that the Company at a future date may file a registration or offering statement
(the Registration Statement) with the Securities and Exchange Commission to
facilitate an underwritten public offering of its securities. The Optionee agrees, for the benefit of the Company,
that should such an underwritten public offering be made and should the
managing underwriter of such offering require, the undersigned will not,
without the prior written consent of the Company and such underwriter, during
the Lock Up Period as defined herein: sell, transfer or otherwise dispose of,
or agree to sell, transfer or otherwise dispose of this Option or any of the
Shares acquired upon exercise of this Option during the Lock Up Period; or sell
or grant, or agree to sell or grant, options, rights or warrants with respect
to any of the Shares acquired upon exercise of this Option. The foregoing does not prohibit gifts to
donees or transfers by will or the laws of descent to heirs or beneficiaries
provided that such donees, heirs and beneficiaries shall be bound by the
restrictions set forth herein. The term Lock
Up Period shall mean the lesser of (x) 180 days or (y) the period
during which Company officers and directors are restricted by the managing
underwriter from effecting any sales or transfers of the Shares. The Lock Up Period shall commence on the
effective date of the Registration Statement.
(g)
Not
An Employment Contract
. The Option
will not confer on the Optionee any right with respect to continuance of
employment or other service with the Company or any Subsidiary, nor will it
interfere in any way with any right the Company or any Subsidiary would
otherwise have to terminate or modify the terms of such Optionees employment
or other service at any time.
(h)
No
Rights as Shareholder
. The Optionee
shall have no rights as a shareholder of the Company with respect to any Shares
prior to the date of issuance to the Optionee of a certificate for such Shares.
(i)
Compliance
with Law and Regulations
. This
Option and the obligation of the Company to sell and deliver Shares hereunder
shall be subject to all applicable laws, rules and regulations (including,
but not limited to, federal securities laws) and to such approvals by any
government or regulatory agency as may be required. This Option shall not be exercisable, and the
Company shall not be required to issue or deliver any certificates for Shares
of Stock prior to the completion of any registration or qualification of such
Shares under any federal or state law, or any rule or regulation of any
government body which the Company shall, in its sole discretion, determine to
be necessary or advisable. Moreover,
this Option may not be exercised if its exercise or the receipt of Shares of
Stock pursuant thereto would be contrary to applicable law.
3
(j)
Withholding
. All deliveries and distributions under this
Agreement are subject to withholding of all applicable taxes. The Company is entitled to (a) withhold
and deduct from future wages of the Optionee (or from other amounts that may be
due and owing to the Optionee from the Company), or make other arrangements for
the collection of, all legally required amounts necessary to satisfy any
federal, state or local withholding and employment-related tax requirements
attributable to the Option, or (b) require the Optionee promptly to remit
the amount of such withholding to the Company before acting on the Optionees
notice of exercise of this Option. At
the election of the Optionee, and subject to such rules and limitations as
may be established by the Committee from time to time, such withholding
obligations may be satisfied through the surrender of shares of Stock which the
Optionee already owns, or to which the Optionee is otherwise entitled under
this Agreement.
(k)
Adjustments
. In the event of any reorganization, merger,
consolidation, recapitalization, liquidation, reclassification, stock dividend,
stock split, combination of shares, rights offering, divestiture or
extraordinary dividend (including a spin off), or any other similar change in
the corporate structure or shares of the Company, the Committee (or, if the
Company is not the surviving corporation in any such transaction, the board of
directors of the surviving corporation), in order to prevent dilution or
enlargement of the rights of the Optionee, will make appropriate adjustment
(which determination will be conclusive) as to the number and kind of
securities or other property (including cash) subject to, and the exercise price
of, this Option. No such adjustment
shall result in the value of the Option exceeding the aggregate value of this
Option prior to such adjustment. The
Committee or Board may make such other adjustments as it deems
appropriate. No other issuance by the Company
of shares of stock or any class, or securities convertible into shares of stock
of any class, shall affect, and no adjustment by reason thereof shall be made
with respect to, the number or price of shares of common stock subject to the
Option.
4.
Termination
of Employment
. Upon the termination
of the employment of Optionee prior to the expiration of the Option, the
following provisions shall apply:
(a) Upon
the involuntary termination of Optionees employment or the voluntary
termination or resignation of Optionees employment, the Optionee may exercise
the Option to the extent the Optionee was vested in and entitled to exercise
the Option at the date of such employment termination for a period of three (3) months
after the date of such employment termination, or until the term of the Option
has expired, whichever date is earlier.
To the extent the Optionee was not entitled to exercise this Option at
the date of such employment termination, or if Optionee does not exercise this
Option within the time specified herein, this Option shall terminate.
(b) If
the employment of an Optionee is terminated by the Company for cause, then the
Board or the Committee shall have the right to cancel the Option.
5.
Death,
Disability or Retirement of Optionee
.
Upon the death, Disability or Retirement, as defined herein, of Optionee
prior to the expiration of the Option, the following provisions shall apply:
(a) If
the Optionee is at the time of his Disability employed by the Company or a
Subsidiary and has been in continuous employment (as determined by the
Committee in its sole discretion) since the Date of Grant of the Option, then
the Option may be exercised by the Optionee
4
for one (1) year
following the date of such Disability or until the expiration date of the
Option, whichever date is earlier, but only to the extent the Optionee was
vested in and entitled to exercise the Option at the time of his
Disability. For purposes of this Section 5,
the term Disability shall mean that the Optionee is unable, by reason of a
medically determinable physical or mental impairment, to substantially perform
the principal duties of employment with the Company, which condition, in the
opinion of a physician selected by the Board, is expected to have a duration of
not less than 120 days, unless the Optionee is employed by the Company, a
Parent, a Subsidiary or an Affiliate, pursuant to an employment agreement which
contains a definition of Disability, in which case such definition shall
control. The Committee, in its sole
discretion, shall determine whether an Optionee has a Disability and the date
of such Disability.
(b) If
the Optionee is at the time of his death employed by the Company or a
Subsidiary and has been in continuous employment (as determined by the
Committee in its sole discretion) since the Date of Grant of the Option, then
the Option may be exercised by the Optionees estate or by a person who
acquired the right to exercise the Option by will or the laws of descent and
distribution, for one (1) year following the date of the Optionees death
or until the expiration date of the Option, whichever date is earlier, but only
to the extent the Optionee was vested in and entitled to exercise the Option at
the time of death.
(c) If
the Optionee is at the time of his Retirement employed by the Company or a
Subsidiary and has been in continuous employment (as determined by the
Committee in its sole discretion) since the Date of Grant of the Option, then
the Option may be exercised by the Optionee for one (1) year following the
date of the Optionees Retirement or until the expiration date of the Option,
whichever date is earlier, but only to the extent the Optionee was vested in
and entitled to exercise the Option at the time of Retirement. For purposes of this Section 5,
Retirement of the Optionee shall mean, with the approval of the Committee, the
occurrence of the Optionees Date of Termination on or after the date the
Optionee attains age 55.
(d) If
the Optionee dies within three (3) months after Termination of Optionees
employment with the Company or a Subsidiary the Option may be exercised for
nine (9) months following the date of Optionees death or the expiration
date of the Option, whichever date is earlier, by the Optionees estate or by a
person who acquires the right to exercise the Option by will or the laws of
descent or distribution, but only to the extent the Optionee was vested in and
entitled to exercise the Option at the time of Termination.
6.
Termination
of Relationship for Misconduct; Clawback
.
If the Board or the Committee reasonably believes that the Optionee has
committed an act of misconduct or breach of fiduciary duty, it may suspend the
Optionees right to exercise this option pending a determination by the Board
or the Committee. If the Board or the
Committee determines that the Optionee has committed an act of misconduct or has breached a duty to the
Company, neither the Optionee nor the Optionees estate shall be entitled to
exercise the Option. For purposes of
this Section 6, an act of misconduct shall include embezzlement, fraud,
dishonesty, nonpayment of an obligation owed to the Company, breach of
fiduciary duty or deliberate disregard of the Companys rules resulting in
loss, damage or injury to the Company, or if the Optionee makes an unauthorized
disclosure of any Company trade secret or confidential information, engages in
any conduct constituting unfair competition with respect to the Company, or
induces any party to breach a contract with the Company. In making such determination, the Board or
the Committee shall act fairly and shall give
5
the Optionee an
opportunity to appear and present evidence on the Optionees behalf at a
hearing before the Board or the Committee.
For purposes of this Section 6, an act of misconduct or breach of
fiduciary duty to the Company shall be an event giving the Company the right to
terminate Optionees employment pursuant to Section
of Optionees Employment Agreement with the Company dated
,
which Agreement is incorporated herein by reference. In addition, misconduct shall include willful
violations of federal or state securities laws.
In making such determination, the Board or the Committee shall act
fairly and shall give the Optionee an opportunity to appear and present
evidence on the Optionees behalf at a hearing before the Board or the
Committee. In addition, if the Company,
based upon an opinion of legal counsel or a judicial determination, determines
that Section 304 of the Sarbanes-Oxley Act of 2002 is applicable to
Optionee hereunder, to the extent that the Company is required to prepare an
accounting restatement due to the material noncompliance of the Company, as a
result of misconduct, with any financial reporting requirement under the
securities laws, Optionee shall reimburse the Company for any compensation
received by Optionee from the Company during the 12-month period following the
first public issuance or filing with the Securities and Exchange Commission
(whichever first occurs) of the financial document embodying such financial
reporting requirement and any profits received from the sale of the Companys
common stock or common stock equivalents, acquired pursuant to this Agreement.
7.
Restrictions on Transfer
.
(a)
Securities Law
Restrictions
. Regardless of whether
the offering and sale of common stock under this Agreement have been registered
under the Securities Act of 1933 (the Act) or have been registered or
qualified under the securities laws of any state, the Company at its discretion
may impose restrictions
upon
the sale, pledge or other transfer of such common stock (including the
placement of appropriate legends on stock certificates or the imposition of
stop-transfer instructions) if, in the judgment of the Company, such
restrictions are necessary or desirable in order to achieve compliance with the
Act, the securities laws of any state or any other law.
(b)
Investment Intent
at Grant
. Optionee represents and
agrees that the Shares to be acquired upon exercising this Agreement will be
acquired for investment, and not with a view to the sale or distribution
thereof.
(c)
Investment Intent
at Exercise
. In the event that
common stock issued under this Agreement is not registered under the Act but an
exemption is available which requires an investment representation or other
representation, Optionee shall represent and agree at the time of exercise that
the common stock being acquired upon exercising the Option is being acquired
for investment, and not with a view to the sale or distribution thereof, and
shall make such other representations as are deemed necessary or appropriate by
the Company and its counsel.
(d)
Legends
. All certificates evidencing
Shares issued under this Agreement in an unregistered transaction shall bear
the following legend (and such other restrictive legends as are required or
deemed advisable under the provisions of any applicable law):
THE SHARES REPRESENTED HEREBY
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
6
1933, AS AMENDED, AND MAY NOT
BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION
THEREOF UNDER SUCH ACT OR AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY
AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.
(e)
Removal
of Legends
. If, in the opinion of
the Company and its counsel, any legend placed on a stock certificate
representing Shares issued under this Agreement is no longer required, the
holder of such certificate shall be entitled to exchange such certificate for a
certificate representing the same number of shares of common stock but without
such legend.
(f)
Administration
. Any determination by the Company and its
counsel in connection with any of the matters set forth in this section shall
be conclusive and binding on Optionee and all other persons.
8.
Heirs
and Successors
. This Agreement shall
be binding upon, and inure to the benefit of, the Company and its successors
and assigns, and upon any person acquiring, whether by merger, consolidation,
purchase of assets or otherwise, all or substantially all of the Companys
assets and business. If any rights
exercisable by the Optionee or benefits deliverable to the Optionee under this
Agreement have not been exercised or delivered, respectively, at the time of
the Optionees death, such rights shall be exercisable by the Designated
Beneficiary, and such benefits shall be delivered to the Designated
Beneficiary, in accordance with the provisions of this Agreement. The Designated Beneficiary shall be the
beneficiary or beneficiaries designated by the Optionee in a writing filed with
the Committee in such form and at such time as the Committee shall
require. If a deceased Optionee fails to
designate a beneficiary, or if the Designated Beneficiary does not survive the
Optionee, any rights that would have been exercisable by the Optionee and any benefits
distributable to the Optionee shall be exercised by or distributed to the legal
representative of the estate of the Optionee.
If a deceased Optionee designates a beneficiary and the Designated
Beneficiary survives the Optionee but dies before the Designated Beneficiarys
exercise of all rights under this Agreement or before the complete distribution
of benefits to the Designated Beneficiary under this Agreement, then any rights
that would have been exercisable by the Designated Beneficiary shall be
exercised by the legal representative of the estate of the Designated
Beneficiary, and any benefits distributable to the Designated Beneficiary shall
be distributed to the legal representative of the estate of the Designated
Beneficiary.
9.
Notices
. Any notice hereunder to the Company shall be
addressed to it at its principal executive offices, located at 9725 South
Robert Trail, Inver Grove Heights, Minnesota 55077, Attention: Chief Executive
Officer; and any notice hereunder to the Optionee shall be addressed to the
Optionee at the address last appearing in the employment records of the
Company; subject to the right of either party to designate at any time
hereunder in writing some other address.
10.
Counterparts
. This Agreement may be executed in two
counterparts each of which shall constitute one and the same instrument.
7
11.
Governing
Law
. This Agreement shall be
governed by and construed in accordance with the laws of the State of
Minnesota, except to the extent preempted by federal law, without regard to the
principles of comity or the conflicts of law provisions of any other
jurisdiction.
IN WITNESS
WHEREOF, MedicalCV, Inc. has caused this Agreement to be executed by its
duly authorized officer and the Optionee has executed this Agreement, both as
of the day and year first above written.
|
|
MEDICALCV, INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name:
|
|
|
|
Title:
|
|
|
|
|
|
|
|
|
|
|
OPTIONEE
|
|
|
|
|
|
|
|
|
|
|
|
|
Name:
|
|
|
|
|
|
|
|
Address:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8
EXHIBIT A
OPTION AND VESTING DATA
Name of Optionee:
Total Number of Shares
Subject to Option:
Date of Grant:
OPTION VESTING SCHEDULE
|
|
|
NO. OF SHARES
|
|
|
DATE
|
|
VESTED
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The above vesting schedule assumes an ongoing
relationship with the Company. Your
rights to exercise the unvested portion of your option will cease upon
termination of relationship with the Company, subject to Change in Control
provisions set forth in Section 3(e) of this Agreement. Reference is made to the Plan and to relevant
sections of the Agreement between you and the Company for your rights to
exercise the vested portion of your option in the event of termination of your
relationship with the Company during lifetime or upon death. The above vesting schedule is in all respects
subject to the terms of those documents.
|
OPTIONEE
|
|
MEDICALCV, INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name:
|
|
|
|
Title:
|
SCHEDULE I -
NOTATIONS AS TO PARTIAL EXERCISE
|
|
|
Number of
|
|
Balance of
|
|
|
|
|
|
|
Date of
|
|
Purchased
|
|
Shares on
|
|
Authorized
|
|
Notation
|
|
|
Exercise
|
|
Shares
|
|
Option
|
|
Signature
|
|
Date
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit 10.6
RESTRICTED STOCK AWARD
RESTRICTED STOCK AWARD AGREEMENT dated as of
,
between MedicalCV, Inc., a Minnesota corporation (the Corporation), and
,
an employee of the Corporation or one of its subsidiaries (the Employee).
WHEREAS, the Board of
Directors of the Corporation has established and the shareholders have approved
the Corporations Amended and Restated 2001 Equity Incentive Plan (the Plan);
WHEREAS, the Compensation
Committee of the Board of Directors of the Corporation (the Committee), in
accordance with the provisions of the Plan, has determined that the Employee is
entitled to a Restricted Stock Award under the Plan;
NOW, THEREFORE, in
consideration of the foregoing and the Employees acceptance of the terms and
conditions hereof, the parties hereto have agreed, and do hereby agree, as
follows:
1.
The Corporation
hereby grants to the Employee, as a matter of separate agreement and not in
lieu of salary or any other compensation for services,
shares of Common Stock of the Corporation on the terms and conditions herein
set forth (the Restricted Shares).
2.
The certificates
representing the Restricted Shares shall be registered in the name of the
Employee and retained in the custody of the Corporation until such time as they
are delivered to the Employee or forfeited to the Corporation in accordance
with the terms hereof (the Restriction
Period). During the Restriction Period,
the Employee will be entitled to vote the Restricted Shares. In addition, any dividends paid on the
Restricted Shares shall, at the option of the Corporation, either be (a) paid
to the Employee in cash as additional compensation, or (b) invested in
additional shares of Common Stock held in custody for the Employee, subject to
the same restrictions as the Restricted Shares, and to be delivered with the
Restricted Shares. Such additional
shares of Common Stock shall be deemed to be included in the definition of Restricted
Shares.
3.
If the Employee shall
have been continuously in the employment of the Corporation for a period of
four years from the date of grant of this Restricted Stock Award, the
Corporation shall deliver to the Employee on or about the fourth anniversary
hereof a certificate, registered in the name of the Employee and free of
restrictions hereunder, representing the total number of Restricted Shares
granted to the Employee pursuant to this Agreement. No payment shall be required from the
Employee in connection with any delivery to the Employee of shares hereunder.
4.
Except in the case of
the Employees death, if the Employee ceases to be an employee of the
Corporation during the Restriction Period, then the Restricted Shares to which
the Employee has not theretofore become entitled pursuant to Section 3
shall be forfeited, and all rights of the Employee in and to such Restricted
Shares shall lapse. In addition, the
Committee shall from time to time determine in its sole discretion whether any
period of nonactive employment, including authorized leaves of absence, or
absence by reason of military or
governmental service,
shall constitute termination of employment for the purposes of this
Section. Upon the death of the Employee
during the Restriction Period, the Employee will be deemed to have been
employed continuously during the entire Restriction Period and the Employees
estate shall be entitled to all rights provided under the terms of this
Restricted Stock Award that the Employee would have been entitled to upon the
end of the Restriction Period.
5.
The granting of this
Restricted Stock Award shall not in any way prohibit or restrict the right of
the Corporation to terminate the Employees employment. The Employee shall have no right to any
prorated portion of the Restricted Shares otherwise deliverable to the Employee
on the anniversary hereof next following a termination of employment (whether
voluntary or involuntary) in respect of a partial year of employment.
6.
Shares of Common
Stock held in custody for the Employee pursuant to this Agreement may not,
before being vested, be sold, transferred, pledged, exchanged, hypothecated or
disposed of by the Employee and shall not be subject to execution, attachment
or similar process.
7.
This Agreement and
each and every obligation of the Corporation relating to the Restricted Stock
Award hereunder are subject to the requirement that if at any time the
Corporation shall determine, upon advice of counsel, that the listing,
registration or qualification of the shares covered hereby upon any securities
exchange or under any state or Federal law, or the consent or approval of any
governmental regulatory body, is necessary or desirable as a condition of or in
connection with the granting hereof or the delivery of shares hereunder, then
the delivery of shares hereunder to the Employee may be postponed until such
listing, registration, qualification, consent or approval shall have been
effected or obtained free of any conditions not acceptable to the Corporation.
8.
Any payment required
under this Agreement shall be subject to all requirements of the law with
regard to income and employment withholding taxes, filings, and making of
reports, and the Corporation and the Employee shall use their best efforts to
satisfy promptly all such requirements, as applicable. In addition to amounts in respect of taxes
which the Corporation shall be required by law to deduct or withhold from any
dividend payments on the Restricted Shares covered hereby, the Corporation may
defer making any delivery of Restricted Shares under this Agreement until
completion of arrangements satisfactory to the Corporation for the payment of
any applicable taxes, whether through share withholding provided for by the
Plan or otherwise.
9.
In the event of a Change
in Control, as that term is defined in the Plan, then the Employee shall have
all the rights specified in Section 9 of the Plan, which, if the acquiring
or surviving company in the Change in Control does not assume this Restricted
Stock Award upon the Change in Control, shall include the immediate lapsing of
all restrictions on the Restricted Shares.
10.
Each capitalized word
used in this Agreement without definition shall have the same meaning set forth
in the Plan, the terms and conditions of which shall constitute an integral
part hereof. For all purposes of this
Agreement, references to employment with the Corporation shall include
employment with any of the Corporations subsidiaries.
2
11.
Any notice which either
party hereto may be required or permitted to give the other shall be in writing
and may be delivered personally or by mail, postage prepaid, addressed to the
Vice President, Finance and Chief Financial Officer of the Corporation at its
principal office and to the Employee at his address as shown on the Corporations
payroll records, or to such other address as the Employee by notice to the
Corporation may designate in writing from time to time.
12.
Employee acknowledges
and understands that the Restricted Shares awarded hereunder constitute
restricted property pursuant to Section 83(a) of the Internal Revenue
Code of 1986, as amended (the Code).
The value of the Restricted Shares shall be taxable to the Employee in
the year the Employee completes the Restriction Period, unless the Employee
timely and properly makes an election under Code Section 83(b) to
accelerate the date on which the Restricted Shares become taxable to the
Employee. Employee acknowledges and
understands that the decision on whether to accelerate the date on which the
Restricted Shares become taxable, pursuant to an election under Code Section 83(b),
is an individual decision. The Employee
shall seek timely advice from a competent tax advisor on whether such an
election is advisable in the Employees situation. If the Employee makes such an election, the
Employee shall promptly advise the Corporation so that the Corporation may
properly report such income and make the necessary income tax withholding from
other compensation the Employee is entitled to receive from the Corporation in
the taxable year, if any. Employee
acknowledges and understands that if the Employee makes an election under Code Section 83(b),
and any of the Restricted Shares are forfeited pursuant to the terms of this
Restricted Stock Award Agreement, Employee will not be entitled to a deduction
for such forfeited Restricted Shares.
13.
Nothing herein
contained shall confer on the Holder any right to continue in the employment of
the Corporation or interfere in any way with the right of the Corporation to
terminate the Holders employment; confer on the Holder any of the rights of a
shareholder, other than as set forth herein, with respect to any of the shares
subject to the Restricted Shares until such shares shall be issued once the
restrictions lapse; affect the Holders right to participate in and receive
benefits under and in accordance with the provisions of any pension,
profit-sharing, insurance, or other employee benefit plan or program of the
Corporation or any of its subsidiaries; or limit or otherwise affect the right
of the Board of Directors of the Corporation (subject to any required approval
by the shareholders) at any time or from time to time to alter, amend, suspend
or discontinue the Plan and the rules for its administration; provided,
however, that no termination or amendment of the Plan may, without the
consent of the Holder, adversely affect the Holders rights
under the Restricted Stock Award.
|
|
MEDICALCV, INC.
|
|
|
|
|
|
By:
|
|
|
|
|
[name]
|
|
|
|
[title]
|
|
|
|
|
|
ACCEPTED:
|
|
|
|
|
|
|
|
|
|
|
|
Employee
|
|
|
|
|
|
|
3
Exhibit 10.7
FIRST AMENDMENT
TO THE
MEDICALCV, INC.
NON-QUALIFIED STOCK OPTION AGREEMENT
WITH
[ ]
Effective February 15,
2008, MedicalCV, Inc. and
have agreed to amend the Non-Qualified Stock Option Agreement dated
as follows:
1. The
definition of change in control in Section 8 shall be amended and
restated as follows:
Change in Control
shall mean:
(a) the acquisition by any person or
group deemed a person under Sections 3(a)(9) and 13(d)(3) of the
Exchange Act (other than the Company and its subsidiaries as determined
immediately prior to that date) of beneficial ownership, directly or indirectly
(with beneficial ownership determined as provided in Rule 13d-3, or any
successor rule, under the Exchange Act), of a majority of the total combined
voting power of all classes of Stock of the Company having the right under
ordinary circumstances to vote at an election of the Board, provided that a
Change in Control shall not occur if a person acquires the majority described
above by virtue of any acquisition of Stock directly from the Company;
(b) the date of approval by the
shareholders of the Company of an agreement providing for the merger or
consolidation of the Company with another corporation or other entity where (x) shareholders
of the Company immediately prior to such merger or consolidation would not
beneficially own following such merger or consolidation shares entitling such
shareholders to a majority of all votes (without consolidation of the rights of
any class of stock to elect directors by a separate class vote) to which all
shareholders of the surviving corporation would be entitled in the election of
directors, or (y) where the members of the Board, immediately prior to
such merger or consolidation, would not, immediately after such merger or
consolidation, constitute a majority of the board of directors of the surviving
corporation; or
(c) the sale of all or substantially all
of the assets of the Company.
|
OPTIONEE
|
|
MEDICALCV, INC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
|
|
Its:
|
|
Date:
|
|
|
|
|
|
|
Date:
|
|
|
|
|
|
|
|